Omega-3 Petition Seeks Unqualified Blood Pressure, CHD Claims
This article was originally published in The Tan Sheet
Executive Summary
The trade group Global Organization for EPA and DHA Omega-3 petitions FDA for an unqualified health claim related to reduced blood pressure as a surrogate marker for coronary heart disease risk.